BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22373851)

  • 1. [Assessment of the sensitizing potency of cosmetic ingredients and commodities. How will the ingredients of cosmetics and commodities be tested in Europe today and tomorrow?].
    Peiser M; Platzek T; Luch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):373-9. PubMed ID: 22373851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmetics as causes of allergic contact dermatitis.
    Dooms-Goossens A
    Cutis; 1993 Nov; 52(5):316-20. PubMed ID: 8299396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis and cosmetics.
    Watkins S; Zippin J
    Cutis; 2012 Oct; 90(4):201-4. PubMed ID: 23259208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranking of hair dye substances according to predicted sensitization potency: quantitative structure-activity relationships.
    Søsted H; Basketter DA; Estrada E; Johansen JD; Patlewicz GY
    Contact Dermatitis; 2004; 51(5-6):241-54. PubMed ID: 15606648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis to cosmetics.
    Park ME; Zippin JH
    Dermatol Clin; 2014 Jan; 32(1):1-11. PubMed ID: 24267417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact allergy to the 26 specific fragrance ingredients to be declared on cosmetic products in accordance with the EU cosmetics directive.
    Heisterberg MV; Menné T; Johansen JD
    Contact Dermatitis; 2011 Nov; 65(5):266-75. PubMed ID: 21943251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin sensitisation.
    Basketter D; Casati S; Gerberick GF; Griem P; Philips B; Worth A
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():83-103. PubMed ID: 16194142
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategy to decrease the risk of adverse effects of fragrance ingredients in cosmetic products.
    Jansson T; Lodén M
    Am J Contact Dermat; 2001 Sep; 12(3):166-9. PubMed ID: 11526523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural ingredients in cosmetic products-A suggestion for a screening series for skin allergy.
    Bruusgaard-Mouritsen MA; Johansen JD; Zachariae C; Kirkeby CS; Garvey LH
    Contact Dermatitis; 2020 Oct; 83(4):251-270. PubMed ID: 32248558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects in allergic contact dermatitis.
    Mortz CG; Andersen KE
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):428-32. PubMed ID: 18769196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergy to cosmetics: a literature review.
    Alani JI; Davis MD; Yiannias JA
    Dermatitis; 2013; 24(6):283-90. PubMed ID: 24201464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
    Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
    Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myths, beliefs and fragrance allergy.
    Contact Dermatitis; 2013 Oct; 69(4):193-5. PubMed ID: 24028782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Good opportunities to prevent contact eczema through legislation].
    Lidén C
    Lakartidningen; 2002 Feb; 99(7):651-4. PubMed ID: 11887712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupled exposure to ingredients of cosmetic products: I. Fragrances.
    Uter W; Yazar K; Kratz EM; Mildau G; Lidén C
    Contact Dermatitis; 2013 Dec; 69(6):335-41. PubMed ID: 24102121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.